ArticleFrontiers in genetics2026
Stereo-cell coupled with single-cell transcriptomics identifies a transitional metabolic state in maturing skeletal muscle myofibers.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identification of skeletal muscle fiber types and metabolic reprogramming are crucial for postnatal muscle maturation, but high-resolution metabolism and spatial heterogeneity of muscle fibers in mid-maturation remain poorly understood. Our study performed single-cell RNA sequencing (scRNA-seq) and single-cell nuclear RNA sequencing (snRNA-seq) on five hind limb muscles from 5-week-old mice, combined with Stereo-cell at single muscle fiber resolution, to elucidate myofiber subtype maturation and its metabolic changes. Integrating scRNA-seq and snRNA-seq data, a comprehensive mouse skeletal muscle cell atlas was constructed, demonstrating the complementary advantages of the two techniques in capturing interstitial cells and multinucleated muscle fibers. Our analysis resolved a continuous maturational lineage from type I to IIB myonuclei (IIB_1-3). Notably, the IIB_3 myonuclei subtype exhibited a dual hypermetabolic phenotype, with increased oxidative phosphorylation (OXPHOS) and glycolytic activity, which differs from the purely glycolytic phenotype observed in adult mice. Stereo-cell further validated this transitional metabolic state and revealed spatial heterogeneity within individual IIB myofibers, with localized high-oxidation regions. Furthermore, we observed a mixed myofiber phenotype, with subtype-specific myosin heavy chain expression enriched at the myofiber terminals, indicating directional transformation of myofiber during maturation. In summary, this study reveals a previously undescribed transitional metabolic feature of IIB-type myofiber during postnatal muscle maturation and elucidates the spatial metabolic heterogeneity of myofiber, providing new insights into the regulatory mechanisms of skeletal muscle developmental plasticity and metabolic specialization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.